Consistent with the in vitro data, Nlrp3/miR-155 double knockout allo-HCT recipient mice displayed no increased protection from GvHD compared to Nlrp3−/− recipients, indicating a functional connection between miR-155 and the Nlrp3 inflammasome (15). Here, NLRP3 is linked to graft versus host disease.